C. Dehaas

发表

Tachykinin-induced dyspnea in conscious guinea pigs.

R. Krell, E. J. Kusner, C. Buckner, 1992, European journal of pharmacology.

Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.

S. Snyder, J. Stewart, D. Manning, 1988, Proceedings of the National Academy of Sciences of the United States of America.

The pre-clinical pharmacology of the inhaled muscarinic antagonist GSK573719 predicts once-daily clinical dosing

J. Foley, W. Rumsey, M. Salmon, 2011 .

Preclinical Exploration of the Potential Antiinflammatory Properties of the Peptide Leukotriene Antagonist ICI 204,219 (Accola™)

R. Krell, E. J. Kusner, C. Buckner, 1994, Annals of the New York Academy of Sciences.

The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses.

R. Krell, E. J. Kusner, C. Buckner, 1994, European journal of pharmacology.

A bradykinin antagonist inhibits carrageenan edema in rats

R. Burch, C. Dehaas, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Antinociceptive effects of bradykinin antagonists.

S. Snyder, J. Stewart, S. Enna, 1987, European journal of pharmacology.

D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II

J. Connor, R. Burch, J. Togo, 1989, Peptides.

[Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.

S. G. Farmer, R. Burch, J. Togo, 1989, The Journal of pharmacology and experimental therapeutics.

Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases

H. Sarau, J. Foley, W. Rumsey, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.

Dwight M. Morrow, Wei-Chang Fu, H. Sarau, 2008, Journal of medicinal chemistry.